# Clinical Study of Esketamine in Patients With Sepsis Undergoing Invasive Mechanical Ventilation

> **NCT07556172** · PHASE4 · ACTIVE_NOT_RECRUITING · sponsor: **Second Affiliated Hospital of Nanchang University** · enrollment: 80 (estimated)

## Conditions studied

- Sepsis
- Mechanical Ventilation

## Interventions

- **DRUG:** Esketamine
- **DRUG:** Remifentanil

## Key facts

- **NCT ID:** NCT07556172
- **Lead sponsor:** Second Affiliated Hospital of Nanchang University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2025-01-01
- **Primary completion:** 2026-06-30
- **Final completion:** 2026-06-30
- **Target enrollment:** 80 (ESTIMATED)
- **Last updated:** 2026-04-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07556172

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07556172, "Clinical Study of Esketamine in Patients With Sepsis Undergoing Invasive Mechanical Ventilation". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT07556172. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*